Results of a randomised phase II study of cisplatin plus 5-fluorouracil versus cisplatin plus 5-fluorouracil with alpha-interferon in metastatic pancreatic cancer: an EORTC gastrointestinal tract cancer group trial.

Wagener, D J T; Wils, J A; Kok, T C; Planting, A; Couvreur, M L; Baron, B

Wagener, D J T; Wils, J A; Kok, T C; Planting, A; Couvreur, M L; Baron, B.

Affiliation

Wagener DJ; UMC Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands. d.wagener@onco.azn.nl

Eur J Cancer ; 38(5): 648-53, 2002 Mar.

Article in En | MEDLINE | ID: mdl-11916546

Subject(s)

Adenocarcinoma/drug therapy; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Pancreatic Neoplasms/drug therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Cisplatin/administration & dosage; Cisplatin/adverse effects; Disease-Free Survival; Female; Fluorouracil/administration & dosage; Fluorouracil/adverse effects; Humans; Interferon alpha-2; Interferon-alpha/administration & dosage; Interferon-alpha/adverse effects; Male; Middle Aged; Recombinant Proteins; Survival Rate; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur J Cancer Year: 2002 Document type: Article Affiliation country: Netherlands Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links